Phyllis Johnson

Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions

Yuhua Bao, Katherine Wen, Phyllis Johnson et al. · Health Affairs · 2018 · 89 citations · Full text

Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?

Angélica Meinhofer, Arthur Robin Williams, Phyllis Johnson et al. · Journal of Substance Abuse Treatment · 2019 · 50 citations · Full text

Opioid Epidemic, Substance Abuse, Substance Use +14

Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients

Emma Boswell Dean, Phyllis Johnson, Amelia M. Bond · JAMA Network Open · 2021 · 29 citations · Full text

First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults

Yong-Kang Zhang, Phyllis Johnson, Philip J. Jeng et al. · Journal of General Internal Medicine · 2018 · 26 citations · Full text

Opioid Epidemic, Substance Abuse, Harm Reduction +13

Barriers of HIPAA Regulation to Implementation of Health Services Research

Jay J. Shen, Linda F. Samson, Elmer L. Washington et al. · Journal of Medical Systems · 2006 · 25 citations

Healthcare Provision, Health Policy, Medical Privacy +6